Skip to main content

Table 8 Multivariate Analysis for thromboembolic events

From: Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!

Factor

Odds Ratio

95% Confidence Limits

P-value

Primary Tumor (Gastric vs. Others)

3.377

1.759–6.483

0.0003

Gender (Female vs. Male)

1.732

1.152–2.605

0.0083

Khorana risk group (High vs. Others)

1.387

0.842–2.285

0.1992

Central Venous Catheter (Presence vs. Absence)

1.098

0.603–1.999

0.7599

Stage (IV vs. Early stage)

1.665

1.054–2.63

0.0289